Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

On November 14, 2022, the board of directors (the "Board") of Apeiron Capital Investment Corp. (the "Company") appointed Charles Aggouras as a director and as a member of the audit committee and nominating and corporate governance committee of the Board (the "Committees").

Mr. Aggouras, age 55, has served as President and Chief Executive Officer of GFC Development Inc., a general contracting, real estate development and investment firm, since 1998. He has more than 25 years of extensive real estate, financial and entrepreneurial experience to all facets of the commercial and residential real estate market. As a registered representative, he has performed financial advisory, portfolio management, estate, and retirement planning services for various financial institutions. He received a BSBA degree in Accounting and Financing from Suffolk University in 1990.

Mr. Aggouras replaced Siamak Taghaddos as a member of the Board and as a member of the Committees. Mr. Taghaddos resigned as a director and a member of the Committees on November 14, 2022. Mr. Taghaddos's resignation did not result from any disagreement with the Company concerning any matter relating to the Company's operations, policies or practices.

There are no family relationships between Mr. Aggouras and any director, executive officer, or person nominated or chosen by the Company to become an executive officer of the Company. There are no transactions between the Company and Mr. Aggouras that are subject to disclosure under Item 404(a) of Regulation S-K.

Item 5.08 Shareholder Director Nominations.

To the extent applicable, the information in Item 8.01 of this Form 8-K is incorporated by reference into this Item 5.08.




 Item 8.01 Other Events.

On November 17, 2022, the Company determined that a special meeting of its stockholders will be held in lieu of its 2021 Annual Meeting of Stockholders (the "Meeting" ) on or about December 22, 2022. The time and location of the Meeting will be as set forth in the Company' s definitive proxy statement for the Meeting to be filed with the Securities and Exchange Commission (the "SEC" ). Pursuant to the Company' s bylaws (the "Bylaws" ), stockholders seeking to bring business before the Meeting or to nominate candidates for election as directors at the Meeting must deliver such proposals or nominations to the principal executive offices of the Company at 175 Federal Street, Suite 875 Boston, Massachusetts 02110, Attention: Secretary, no later than November 28, 2022. Any stockholder proposal or director nomination must also comply with the requirements of Delaware law, the rules and regulations promulgated by the SEC and the Bylaws.

© Edgar Online, source Glimpses